首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   363篇
  免费   11篇
  国内免费   77篇
儿科学   29篇
妇产科学   1篇
基础医学   23篇
口腔科学   6篇
临床医学   80篇
内科学   87篇
皮肤病学   15篇
神经病学   9篇
特种医学   93篇
外科学   16篇
综合类   24篇
预防医学   5篇
眼科学   5篇
药学   44篇
  1篇
中国医学   1篇
肿瘤学   12篇
  2021年   3篇
  2019年   2篇
  2018年   2篇
  2017年   3篇
  2016年   4篇
  2015年   8篇
  2014年   9篇
  2013年   7篇
  2012年   5篇
  2011年   4篇
  2010年   5篇
  2009年   11篇
  2008年   1篇
  2007年   54篇
  2006年   9篇
  2005年   13篇
  2004年   1篇
  2003年   2篇
  2001年   5篇
  2000年   11篇
  1999年   8篇
  1998年   22篇
  1997年   31篇
  1996年   25篇
  1995年   22篇
  1994年   18篇
  1993年   14篇
  1992年   4篇
  1991年   6篇
  1990年   7篇
  1989年   10篇
  1988年   15篇
  1987年   6篇
  1986年   10篇
  1985年   12篇
  1984年   4篇
  1983年   5篇
  1982年   13篇
  1981年   12篇
  1980年   9篇
  1979年   3篇
  1978年   6篇
  1977年   5篇
  1976年   8篇
  1975年   8篇
  1971年   2篇
  1970年   1篇
  1967年   1篇
  1964年   1篇
  1950年   1篇
排序方式: 共有451条查询结果,搜索用时 31 毫秒
1.
2.
Molecular genetic characterization of XRCC4 function   总被引:2,自引:0,他引:2  
XRCC4 is a generally expressed protein of 334 amino acids that is involved in the repair of DNA double-strand breaks and in V(D)J recombination, but its function is unknown. In this study, we have used a mutational approach and the yeast two-hybrid method to perform an initial characterization of this protein. We show that the XRCC4 protein is located in the nucleus. We also demonstrate that several potential phosphorylation sites are not required for XRCC4 function in a transient V(D)J recombination assay. In addition, we show that XRCC4 forms a homodimer in vivo with the homodimerization domain being located within amino acids 115-204. Finally, we define a core domain of XRCC4 that functions in V(D)J recombination and comprises amino acids 18-204. Potential functions of XRCC4 are discussed.   相似文献   
3.
0 引言一氧化氮(Nitric oxide,NO)是一种具有活跃生物化学性质的无机小分子. NO对许多肿瘤细胞和微生物有细胞毒性[1],为探讨NO与肿瘤的关系,我们检测了119例恶性肿瘤患者血清及尿液中的NO.  相似文献   
4.
Impulsivity is an important feature of multiple neuropsychiatric disorders, and individual variation in the degree of inherent impulsivity could play a role in the generation or exacerbation of problematic behaviors. Serotonin (5-HT) actions at the 5-HT2AR receptor (5-HT2AR) promote and 5-HT2AR antagonists suppress impulsive action (the inability to withhold premature responses; motor impulsivity) upon systemic administration or microinfusion directly into the medial prefrontal cortex (mPFC), a node in the corticostriatal circuit that is thought to play a role in the regulation of impulsive action. We hypothesized that the functional capacity of the 5-HT2AR, which is governed by its expression, localization, and protein/protein interactions (eg, postsynaptic density 95 (PSD95)), may drive the predisposition to inherent impulsive action. Stable high-impulsive (HI) and low-impulsive (LI) phenotypes were identified from an outbred rodent population with the 1-choice serial reaction time (1-CSRT) task. HI rats exhibited a greater head-twitch response following administration of the preferential 5-HT2AR agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) and were more sensitive to the effects of the selective 5-HT2AR antagonist M100907 to suppress impulsive action relative to LI rats. A positive correlation was observed between levels of premature responses and 5-HT2AR binding density in frontal cortex ([3H]-ketanserin radioligand binding). Elevated mPFC 5-HT2AR protein expression concomitant with augmented association of the 5-HT2AR with PSD95 differentiated HI from LI rats. The observed differential sensitivity of HI and LI rats to 5-HT2AR ligands and associated distinct 5-HT2AR protein profiles provide evidence that spontaneously occurring individual differences in impulsive action reflect variation in the cortical 5-HT2AR system.  相似文献   
5.
6.
7.
8.
BACKGROUND: Assays that detect human T-lymphotropic virus type I and type II antibody (HTLV-I/II) are widely used in the routine screening of blood donors. STUDY DESIGN AND METHODS: Four commercially available anti-HTLV-I (Fujirebio and Organon Teknika) or -HTLV-I/II assays (Murex and Ortho) were evaluated in various serum panels: A) HTLV-I-positive specimens (n = 41), confirmed by Western blot and polymerase chain reaction; B) a commercially available anti-HTLV-I/II panel; C) serial dilutions of sera from HTLV-I-positive individuals (n = 30), confirmed by immunofluorescence assay and Western blot: D) serial dilutions of HTLV-II-positive blood donors (n = 20), confirmed by Western blot and polymerase chain reaction, and E) sera from first-time blood donors (n = 1055). RESULTS: All four assays elicited reactions in all 82 HTLV-I- positive samples in Panels A, B, and C. Of 32 HTLV-II-positive specimens in Panels B and D, 31 (96.9%) reacted in the Organon Teknika assay and all 32 reacted in the remaining tests. Probit analysis of test results in Panels C and D indicated that the Fujirebio test was the most sensitive assay, followed by Organon Teknika, Ortho, and Murex. The specificities of Fujirebio, Murex, Organon Teknika, and Ortho tests in 1055 first-time blood donors were 99.9, 100, 99.6, and 99.9 percent, respectively. CONCLUSION: All four studied assays for detecting HTLV-I or HTLV-I/II antibodies are appropriate as screening tests.  相似文献   
9.
10.
Tuberculous mastitis is rare, especially in Western countries. We describe a case where the interferon gamma release assay blood test led to diagnosis and successful treatment of the disease.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号